influenza
virus
iav
caus
annual
season
human
respiratori
diseas
epidem
addit
iav
implic
occasion
pandem
inordin
health
econom
consequ
studi
iav
vitro
vivo
requir
use
labori
secondari
methodolog
identifi
virusinfect
cell
circumv
requir
replicationcompet
iav
express
easili
traceabl
report
protein
use
discuss
develop
applic
recombin
replicationcompet
iav
harbor
divers
fluoresc
bioluminesc
report
gene
differ
locat
viral
genom
virus
employ
vitro
vivo
studi
screen
neutral
antibodi
antivir
compound
identif
host
factor
involv
viral
replic
cell
tropism
develop
vaccin
assess
viral
infect
dynam
summari
reporterexpress
replicatingcompet
iav
repres
power
tool
studi
iav
vitro
vivo
na
protein
cleav
sialic
acid
moieti
sialyloligosaccharid
facilit
releas
nascent
virion
importantli
na
major
target
antivir
drug
oseltamivir
block
aforement
cleavag
prevent
viral
dissemin
prevent
infect
figur
influenza
viru
iav
genom
organ
virion
structur
genom
organ
eight
singlestrand
negativesens
viral
v
rna
segment
pa
ha
np
na
ns
iav
indic
black
box
end
vrna
indic
noncod
region
ncr
hatch
box
indic
packag
signal
present
end
vrna
respons
effici
encapsid
nascent
virion
number
repres
nucleotid
length
ncr
packag
signal
b
virion
structur
iav
surround
lipid
bilay
contain
two
viral
glycoprotein
hemagglutinin
ha
respons
bind
sialic
acidcontain
receptor
neuraminidas
na
respons
viral
releas
infect
cell
also
virion
membran
ion
channel
matrix
protein
viral
lipid
bilay
protein
layer
compos
inner
surfac
envelop
matrix
protein
play
role
virion
assembl
bud
nuclear
export
protein
nep
involv
nuclear
export
viral
ribonucleoprotein
vrnp
complex
underneath
core
viru
made
eight
vrna
segment
encapsid
viral
nucleoprotein
np
associ
vrnp
complex
viral
rnadepend
rna
polymeras
rdrp
complex
made
three
polymeras
subunit
pa
togeth
viral
np
minim
compon
requir
viral
replic
transcript
replic
transcript
process
influenza
vrna
carri
np
three
polymeras
subunit
acid
pa
two
basic
protein
encod
three
largest
vrna
segment
unlik
mani
rna
virus
influenza
viral
genom
replic
transcript
occur
nucleu
infect
cell
newli
synthes
vrnp
complex
export
nucleu
cytoplasm
nuclear
export
protein
nep
matrix
protein
assembl
virion
plasma
membran
small
iav
genom
abl
transcrib
multipl
viral
gene
singl
segment
multipl
mechan
mechan
includ
altern
splice
viral
mrna
ns
segment
noncanon
translat
nonaug
initi
ribosom
frameshift
moreov
extend
code
capabl
viral
genom
iav
encod
protein
contain
one
function
viru
infect
wellstudi
multifunct
iav
protein
nonstructur
protein
virus
express
high
level
infect
cell
determin
virul
function
sever
way
defeat
cellular
innat
antivir
mechan
encod
collinear
mrna
deriv
vrna
segment
eight
ns
upon
splice
result
synthesi
nep
although
natur
reservoir
iav
wild
waterfowl
shorebird
iav
expand
host
rang
mani
avian
mammalian
speci
undefin
adapt
process
involv
mutat
genom
reassort
crossspeci
jump
characterist
allow
gener
potenti
pandem
strain
addit
antigen
drift
occur
viru
accumul
mutat
preclud
bind
preexist
antibodi
produc
variant
virus
escap
immun
iav
three
ha
subtyp
thu
gain
abil
transmit
effici
among
human
addit
iav
subtyp
also
thought
repres
pandem
threat
cross
speci
barrier
infect
human
given
persist
threat
pose
iav
infect
acceler
develop
novel
countermeasur
iav
infect
increas
biolog
understand
associ
viral
infect
imper
current
avail
option
counter
iav
includ
vaccin
antivir
two
class
antivir
approv
iav
target
either
ion
channel
function
matrix
protein
neuraminidas
function
na
protein
howev
antivir
compound
problem
term
safeti
emerg
viral
resist
vaccin
due
induct
steril
immun
primari
mean
prevent
iav
infect
howev
current
avail
vaccin
moder
efficaci
chang
season
moreov
gener
vaccin
highli
pathogen
iav
case
pandem
outbreak
requir
time
therefor
develop
new
antivir
strategi
combat
iav
infect
urgent
need
current
tradit
technolog
identifi
antivir
iav
extens
review
review
focu
applic
limit
replicationcompet
iav
harbor
fluoresc
andor
luminesc
report
gene
better
knowledg
influenza
viru
genom
importantli
identif
vrna
packag
signal
becom
possibl
engin
replicationcompet
iav
encod
exogen
gene
stabl
incorpor
foreign
gene
replicationcompet
reporterexpress
iav
allow
effect
track
viral
infect
vitro
vivo
enabl
robust
quantit
readout
readout
use
high
throughput
screen
ht
assess
viral
infect
tissu
cultur
cell
anim
model
without
use
secondari
approach
identifi
presenc
viru
influenza
virus
iav
envelop
virus
within
famili
orthomyxovirida
genom
iav
contain
eight
singlestrand
negativesens
viral
rna
vrna
segment
figur
vrna
contain
long
central
code
region
flank
termini
noncod
region
ncr
serv
promot
initi
replic
transcript
viral
heterotrimer
polymeras
complex
vrna
resid
within
virion
viral
ribonucleoprotein
vrnp
complex
bound
viral
polymeras
mani
copi
nucleoprotein
np
figur
iav
import
pathogen
exert
dramat
impact
public
health
global
economi
caus
annual
recurr
epidem
result
approxim
three
five
million
case
sever
ill
death
worldwid
iav
classifi
basi
antigen
properti
envelop
glycoprotein
hemagglutinin
ha
neuraminidas
na
ha
na
subtyp
ha
protein
critic
bind
cellular
receptor
fusion
viral
endosom
membran
addit
infect
iav
result
protect
immun
mediat
least
part
antibodi
viral
ha
key
immunogen
natur
immun
vaccin
approach
major
advantag
use
recombin
replicationcompet
iav
flexibl
support
presenc
report
gene
fluoresc
luciferas
protein
differ
viral
segment
report
gene
provid
good
readout
viral
replic
compat
ht
set
moreov
report
gene
noteworthi
role
multipl
applic
vitro
vivo
ideal
report
gene
encod
protein
whose
activ
detect
high
sensit
endogen
background
amen
assay
sensit
quantit
reproduc
addit
report
protein
detect
directli
inher
characterist
fluoresc
enzymat
activ
well
indirectli
antibodybas
assay
like
western
blot
although
multipl
report
gene
use
review
focu
replicationcompet
recombin
iav
harbor
fluoresc
luciferas
report
two
categori
protein
glow
type
system
fluoresc
bioluminesc
creat
photon
energi
transit
excit
state
correspond
ground
state
howev
differ
excit
state
gener
glow
mechan
fluoresc
protein
gener
first
absorb
energi
one
color
light
excit
emit
energi
differ
wavelength
hand
bioluminesc
glow
result
exotherm
chemic
reaction
first
bioluminesc
report
identifi
name
aequorin
calciumactiv
photoprotein
aequorea
victoria
jellyfish
howev
discoveri
green
fluoresc
protein
gfp
earli
gene
first
clone
ultim
herald
new
era
molecular
biolog
gfp
identifi
protein
lack
bioluminesc
properti
aequorin
abl
gener
fluoresc
illumin
uv
light
recent
fluoresc
bioluminesc
protein
speci
identifi
mutant
variant
develop
differ
glow
properti
result
rapid
expans
color
spectrum
importantli
newli
develop
technolog
excit
detect
emiss
help
expand
rang
applic
clone
luc
gene
firefli
photinu
pyrali
provid
first
luciferas
report
system
widespread
util
mammalian
cell
luciferas
famili
enzym
gener
bioluminesc
signal
monooxygen
luciferin
substrat
util
atp
cosubstr
luciferin
luciferas
catalysi
produc
light
luciferas
enzym
isol
differ
anim
speci
differ
variabl
light
emiss
sensit
emiss
durat
time
accommod
differ
experiment
design
multipl
luciferas
enzym
combin
multiplex
analys
includ
vivo
imag
moreov
new
secret
version
luciferas
shorter
version
luciferas
gene
describ
facilit
detect
report
gene
express
upon
viral
infect
properti
report
gene
must
consid
per
experi
basi
differ
gene
serv
differ
purpos
choos
best
report
gene
assay
depend
type
studi
tabl
exampl
observ
local
fluoresc
gene
like
gfp
conveni
howev
quantit
purpos
luciferas
use
wholebodi
imag
increasingli
use
mice
small
laboratori
anim
purpos
luciferas
report
prefer
fluoresc
protein
fluoresc
requir
excit
light
travel
locat
fluoresc
probe
luciferas
substrat
administ
system
fluoresc
target
vivo
excit
light
scatter
tissu
plane
target
reduc
intens
moreov
sensit
specif
fluoresc
imag
frequent
disturb
tissu
autofluoresc
result
substanti
background
problem
aris
tissu
penetr
autofluoresc
reduc
fluoresc
protein
visual
ex
vivo
bioluminesc
report
also
limit
sinc
product
light
requir
presenc
compon
involv
oxid
reaction
although
reagent
like
atp
exist
tissu
concentr
vari
anatom
locat
physiolog
condit
anim
moreov
substrat
luciferin
must
inject
anim
gener
bioluminesc
signal
note
advanc
instrument
use
molecular
imag
improv
sensit
resolut
help
minim
aforement
limit
type
report
gene
iav
segment
genom
allow
opportun
tag
variou
gene
segment
fluoresc
luminesc
report
thu
allow
visual
andor
quantit
observ
report
gene
express
sever
caveat
must
consid
design
iav
encod
report
gene
first
viru
segment
small
kb
length
toler
larg
insert
second
ad
report
gene
end
viral
segment
disrupt
packag
signal
locat
end
viral
rna
requir
effici
virion
assembl
third
import
evalu
stabil
insert
report
gene
sinc
replicatingcompet
iav
describ
easili
lose
insert
report
gene
caus
associ
report
instabl
total
understood
howev
relat
size
natur
insert
foreign
sequenc
overcom
hurdl
multipl
strategi
employ
rescu
recombin
iav
harbor
report
gene
lead
abund
reportercontain
iav
tabl
iav
segment
figur
encod
protein
play
import
role
viral
genom
transcript
initi
gener
rna
fragment
cellular
premrna
molecul
serv
primer
viral
transcript
also
modul
vrnp
assembl
thought
contribut
viral
replicas
transcriptas
activ
final
iav
major
host
rang
virul
determin
schemat
represent
segment
wild
type
wt
report
b
c
iav
gene
segment
contain
noncod
region
ncr
packag
signal
open
read
frame
orf
gene
replicationtranscript
virion
incorpor
protein
express
respect
nucleotid
length
ncr
segment
indic
b
fusion
protein
report
gene
fuse
nativ
orf
tripl
alanin
aaa
spacer
c
bicistron
transcript
report
gene
insert
autocleavag
site
separ
report
gene
packag
signal
encod
terminu
mutat
minim
interfer
nativ
duplic
ncrproxim
region
kdel
lysineaspart
acidglutam
acidleucin
signal
sequenc
insert
endoplasm
reticulumretent
report
gene
packag
signal
duplic
protein
stop
transcript
signal
ncr
terminu
studi
examin
intracellular
vrnp
traffick
previous
limit
due
difficulti
visual
movement
live
cell
solv
avilov
et
al
util
splitgfp
ctermin
amino
acid
aa
gfp
fuse
figur
gfp
reconstitut
occur
transcompl
transient
transfect
cell
tabl
gfptag
viru
backbon
influenza
wsn
deem
viru
similar
albeit
slightli
diminish
growth
kinet
plaqu
phenotyp
compar
wildtyp
wt
wsn
viru
parent
transcompl
madindarbi
canin
kidney
mdck
cell
propag
effici
vitro
distinct
disadvantag
transfect
cell
requir
observ
fluoresc
simplifi
gener
stabl
cell
line
express
gfp
transcompl
domain
addit
gener
mice
express
gfp
domain
either
target
tissu
constitut
could
use
ex
vivo
analysi
viral
infect
avilov
et
al
use
monitor
traffick
vrnp
infect
use
dynam
light
microscopi
live
imag
cell
infect
splitgfpbas
viru
demonstr
cours
infect
vrnp
accumul
pericentriolarli
follow
wide
distribut
throughout
cytoplasm
accumul
plasma
membran
occasion
quick
movement
vrnp
also
detect
cytoplasm
report
actinand
microtubuledepend
result
agreement
previou
observ
fix
cell
furthermor
avilov
et
al
observ
vrnp
associ
tabl
host
protein
involv
cellular
vesicl
traffick
find
reiter
previou
report
vrnp
accumul
contain
particl
author
use
fluoresc
reson
energi
transfer
microscopi
suggest
direct
vrnp
interact
propos
vrnp
traffic
cytoplasm
recycl
endosom
via
interact
influenza
polymeras
function
tightli
regul
proteinprotein
interact
subunit
toler
larg
foreign
protein
addit
insert
viral
peptid
extens
use
gener
replicationcompet
iav
contain
foreign
sequenc
viral
sequenc
mediat
cotransl
ribosom
skip
protein
cleavag
separ
two
distinct
polypeptid
equimolar
amount
collinear
transcript
therefor
express
singl
mrna
separ
control
singl
viral
promot
heaton
et
al
clone
gaussia
luciferas
gluc
gene
ctermin
end
separ
viral
open
read
frame
orf
report
via
footandmouth
diseas
viru
fmdv
peptid
sequenc
figur
tabl
importantli
addit
foreign
sequenc
end
vrna
disrupt
packag
signal
need
assembl
progeni
virion
overcom
packag
restrict
complet
packag
signal
duplic
gluc
upstream
ncr
moreov
silent
mutat
introduc
origin
packag
signal
orf
elimin
origin
packag
signal
addit
endoplasm
reticulum
er
retent
sequenc
kdel
ad
cterminu
gluc
prevent
secret
viru
rescu
backbon
influenza
apuerto
embryon
chicken
egg
log
lower
replic
level
compar
wt
recombin
viru
stabl
least
four
serial
passag
egg
major
interest
iav
field
character
antibodi
bind
conserv
stalk
region
ha
glycoprotein
domain
much
less
variabl
head
region
therapeut
target
domain
potenti
abil
crossprotect
multipl
variant
subtyp
iav
use
vivo
character
therapeut
potenti
two
stalkreact
monoclon
antibodi
mab
stalkreact
mab
bind
mani
iav
exhibit
neutral
activ
plaqu
reduct
assay
abil
broadli
neutral
imped
infect
lung
examin
passiv
transfer
experi
end
mice
given
antibodi
h
infect
lethal
mld
studi
show
morbid
mortal
mice
receiv
antibodi
therapi
mab
also
protect
lethal
challeng
influenza
influenza
mice
mld
plaqu
form
unit
pfu
approxim
time
less
lethal
wt
viru
mld
suggest
recapitul
wtlike
viru
life
cycl
vivo
gene
viru
backbon
transgen
insert
mechan
applic
ref
virushost
interact
wsn
gluc
gaussia
luciferas
fusion
fragment
split
gluc
fuse
cterminu
pa
reconstitut
gluc
activ
fragment
need
cell
yan
et
al
establish
ht
protocol
simultan
identif
pathogenand
hosttarget
hit
candid
either
respiratori
syncyti
viru
rsv
iav
end
author
gener
recombin
wsngluc
figur
tabl
use
recombin
rsvfirefli
dualpathogen
protocol
use
replicationcompet
recombin
virus
show
superior
cost
resourc
effect
moreov
screen
agent
use
new
approach
iav
rsv
clinic
import
human
respiratori
pathogen
precis
map
pathogenhost
interact
essenti
comprehens
understand
process
infect
pathogenesi
interactom
studi
use
multipl
approach
identifi
character
protein
interact
instanc
use
yeast
twohybrid
screen
anim
virus
reflect
pathogen
microenviron
tandem
affin
purif
mass
spectrometri
also
use
approach
distinguish
direct
indirect
interact
new
technolog
thu
need
improv
map
pathogenhost
interact
includ
iav
munier
et
al
gener
set
recombin
iav
contain
fragment
split
gluc
fuse
cterminu
pa
wsn
backbon
figur
tabl
reconstitut
gluc
activ
cell
must
coinfect
two
virus
combin
produc
despit
moder
attenu
vitro
rel
wt
viru
virus
express
viral
fusion
protein
replicationcompet
virus
show
higher
titer
counterpart
upon
multicycl
amplif
mdck
cell
author
use
split
gluc
virus
demonstr
dosedepend
reduct
luciferas
reconstitut
presenc
ribavirin
nucleozin
presenc
amantadin
consist
previous
publish
data
wsn
import
note
luciferas
activ
reduc
inhibit
viral
proteinprotein
interact
reduc
viral
protein
abund
split
gluc
virus
could
thu
use
compound
librari
knockdown
overexpress
assay
identifi
host
factor
affect
viral
replic
rnp
assembl
inhibitor
viru
replic
munier
et
al
modifi
experiment
paramet
detect
binari
interact
iav
polymeras
host
protein
wherebi
singl
viru
use
infect
cell
transfect
host
protein
assay
detect
viralhost
proteinprotein
interact
within
exploratori
set
among
host
factor
identifi
involv
nuclear
import
pathway
compon
nuclear
pore
complex
nucleoporin
mrna
export
factor
nuclear
rna
export
factor
rna
bind
motif
protein
schemat
represent
segment
wt
report
b
virus
describ
figur
influenza
wt
viral
segment
encod
orf
via
altern
start
codon
nucleotid
length
ncr
segment
indic
b
fusion
protein
report
gene
fuse
nativ
orf
short
linker
sl
packag
signal
duplic
protein
stop
transcript
signal
ncr
terminu
nanoluc
nluc
small
molecular
weight
kda
luciferas
light
output
time
greater
popular
luciferas
like
renilla
firefli
advantag
tran
et
al
describ
gener
recombin
wsn
iav
express
nluc
pa
segment
use
autocleavag
sequenc
tabl
iav
segment
figur
encod
polymeras
subunit
pa
previous
shown
toler
fusion
c
terminu
without
disrupt
polymeras
function
moreov
compar
polymeras
subunit
iav
pa
minim
packag
sequenc
end
pa
structur
requir
polymeras
activ
possess
endonucleas
activ
cleav
host
cap
premrna
requir
nuclear
accumul
pa
segment
alter
follow
nucleotid
nt
repeat
packag
signal
segment
refer
patn
figur
anoth
viru
gener
pastn
differ
patn
introduc
silent
mutat
within
termin
nt
pa
code
sequenc
possibl
reliev
competit
multipl
packag
signal
achiev
stabl
report
gene
mainten
repeat
passag
figur
author
show
nluc
wsn
virus
patn
pastn
replic
wt
properti
cultur
vivo
possess
remark
similar
pathogen
lethal
mice
wsn
patn
viru
use
investig
dissemin
iav
mous
lung
use
vivo
imag
system
wsn
patn
virus
encod
either
humansignatur
aviansignatur
use
vivo
assess
host
rang
determin
viral
dissemin
live
mice
expect
mice
infect
wt
wsn
patn
lost
weight
display
robust
bioluminesc
increas
time
contrast
wsn
patn
viru
encod
aviansignatur
sever
restrict
infect
mice
show
littl
weight
loss
bioluminesc
near
background
level
throughout
experi
thu
report
viru
faith
recapitul
known
polymerasemedi
host
rang
restrict
could
therefor
also
use
newli
isol
iav
strain
determin
host
rang
role
speciesspecif
adapt
mutat
patn
pastn
viru
infect
therefor
viabl
model
wsn
infect
vitro
vivo
similarli
tran
et
al
use
system
multimod
bioluminesc
positron
emiss
tomographycomput
tomographi
petct
imag
evalu
effect
oseltamivir
treatment
viral
load
dissemin
inflamm
mice
tabl
figur
influenza
wt
pa
gene
segment
encod
pa
pax
share
ntermin
amino
acid
pa
cterminu
orf
via
ribosom
frame
shift
nucleotid
length
ncr
pa
segment
indic
b
c
bicistron
transcript
pa
report
gene
insert
autocleavag
site
separ
pa
report
gene
packag
signal
encod
terminu
pa
wt
b
mutat
c
minim
interfer
nativ
duplic
ncrproxim
region
pa
fusion
protein
report
gene
fuse
nativ
pa
orf
packag
signal
duplic
protein
stop
transcript
signal
ncr
terminu
tabl
recombin
viru
use
transmiss
studi
ferret
wtlike
kinet
vitro
vivo
transmiss
direct
respiratori
contact
titer
determin
bioluminesc
tissu
cultur
infect
dose
tcid
found
nearli
ident
benefit
use
measur
bioluminesc
reduc
turnaround
time
titer
determin
h
spronken
short
et
al
also
gener
sever
recombin
replicationcompet
iav
harbor
report
gene
pa
segment
tabl
optim
strategi
make
iav
express
report
gene
differ
construct
clone
use
nearinfrar
fluoresc
protein
irfp
firstli
construct
consist
pa
untransl
region
utr
pa
orf
without
stop
codon
short
linker
sequenc
irfp
utr
produc
construct
modifi
insert
duplic
packag
region
dpr
final
two
three
mutat
promot
region
also
introduc
duplic
packag
region
essenti
rescu
irfp
report
viru
effici
wherea
introduct
mutat
result
viru
product
hand
construct
one
result
recombin
viru
express
irfp
vitro
although
viru
titer
lower
wt
reduct
viru
titer
also
observ
mutat
introduc
wt
pa
gene
segment
clone
strategi
later
use
insert
differ
report
includ
enhanc
gfp
egfp
far
fluoresc
protein
frfp
gluc
ffluc
tabl
level
viru
replic
report
express
stabil
report
evalu
strategi
use
gener
egfpexpress
virus
backbon
influenza
highli
pathogen
avian
influenza
hpai
greatest
report
stabil
test
follow
irfp
ffluc
lost
consider
report
activ
four
five
passag
vitro
optim
consist
shorten
duplic
packag
signal
nt
nt
limit
impact
viral
replic
enhanc
egfp
express
versu
evalu
infect
use
vivo
imag
system
ivi
egfp
frfp
show
strong
signal
mous
lung
wherea
author
hypothes
due
low
report
express
loss
report
gene
vivo
sinc
mdck
cell
infect
lung
homogen
becam
fluoresc
due
strong
signal
output
report
stabil
wtlike
replic
characterist
chosen
model
studi
aspect
iav
infect
detect
morpholog
chang
infect
cell
fluoresc
electron
microscopi
em
green
fluoresc
infect
mdck
cell
examin
use
em
found
microvillar
project
viruslik
particl
bud
structur
final
dpr
hpai
virus
rescu
character
vitro
report
virus
rescu
log
less
wt
viru
vitro
importantli
egfp
report
virus
exhibit
fluoresc
stabil
four
serial
passag
convers
lack
stabil
dpr
isol
show
reduc
stabil
avian
strain
vivo
experi
conduct
isol
exclus
signal
came
live
imag
ex
vivo
lung
imag
use
ivi
show
diffus
report
signatur
thu
provid
model
avian
influenza
infect
mice
track
vrna
movement
infect
cell
fluoresc
tag
fuse
viral
protein
involv
vrna
traffick
although
fluoresc
iav
gener
contain
gfp
fuse
viral
protein
involv
vrna
transport
separ
fluoresc
polypeptid
lakdawala
et
al
overcam
limit
fuse
entir
gfp
protein
cterminu
pa
backbon
wsn
iav
wsnpa
gfp
figur
tabl
segment
construct
contain
gfp
stop
codon
duplic
pa
packag
signal
contain
approxim
nt
code
region
upstream
ncr
author
develop
two
novel
imag
tool
system
visual
four
differ
vrna
segment
within
infect
cell
fluoresc
influenza
viru
wsnpa
gfp
track
vrna
dynam
live
cell
product
infect
use
wsnpa
gfp
viru
live
cell
fluoresc
microscopi
investig
abl
show
pagfp
foci
fuse
cytoplasm
remain
state
travel
plasma
membran
addit
use
fluoresc
situ
hybrid
probe
specif
vrna
shown
pagfp
fuse
ha
viral
segment
cytoplasm
infect
cell
overal
data
suggest
vrna
segment
export
individu
segment
sinc
major
foci
extern
nuclear
peripheri
contain
one
vrna
segment
moreov
mani
foci
fewer
vrna
segment
observ
cytoplasm
impli
vrna
segment
export
nucleu
togeth
therefor
author
conclud
vrna
assembl
includ
format
flexibl
subcomplex
export
nucleu
undergo
assembl
en
rout
plasma
membran
via
dynam
coloc
event
segment
iav
figur
encod
na
protein
function
promot
viral
releas
one
major
surfac
viral
antigen
princip
biolog
role
cleavag
termin
sialic
acid
residu
receptor
ha
glycoprotein
receptordestroy
activ
na
resid
distal
head
domain
link
viral
membran
ntermin
hydrophob
transmembran
domain
abil
cleav
sialic
acid
also
thought
help
viru
penetr
mucu
feng
et
al
gener
two
egfpexpress
virus
report
link
na
segment
tabl
na
vrna
packag
signal
includ
ncr
nt
adjac
nt
code
region
ncr
nt
adjac
nt
code
region
maintain
effici
packag
modifi
na
vrna
report
virus
util
autocleavag
site
allow
collinear
express
na
egfp
viru
egfp
gene
preced
site
follow
na
figur
na
gene
preced
egfp
separ
site
figur
author
found
order
viral
gene
fluoresc
report
effect
viral
growth
kinet
plaqu
phenotyp
na
activ
egfp
local
embryon
egg
mdck
human
lung
epitheli
cell
line
viral
growth
kinet
similar
wt
viru
replic
lower
level
log
likewis
expect
form
wtlike
plaqu
larg
comparison
next
amount
na
purifi
virus
compar
wt
viru
virion
possess
nearli
much
na
activ
wt
viru
virion
possess
much
less
na
activ
may
result
egfp
interfer
truncat
ntermin
region
na
protein
addit
na
vrna
packag
effici
test
compar
wt
nearli
naegfp
vrna
segment
packag
virion
egfpna
vrna
segment
packag
virion
local
egfp
two
recombin
virus
also
shown
differ
egfp
produc
uniformli
distribut
throughout
infect
cell
includ
nucleu
na
report
found
cell
membran
author
attribut
dissimilar
virus
differ
recombin
na
segment
report
fuse
na
transmembran
anchor
region
thu
local
membran
could
reduc
presenc
na
membran
limit
viral
releas
author
suggest
membran
bound
egfp
would
use
live
infect
monitor
vivo
attenu
viral
kinet
make
logic
choic
howev
replicationcompet
iav
harbor
fluoresc
report
ineffect
studi
use
ex
vivo
bioluminesc
harbor
model
far
effect
iav
vivo
research
author
also
use
recombin
viru
identif
neutral
antibodi
nab
fluorescenceactiv
cell
sort
fac
fac
provid
rapid
highli
accur
measur
fluoresc
measur
mean
fluoresc
intens
mfi
serial
dilut
mous
serum
preincub
serumfluoresc
viru
mixtur
use
infect
mdck
cell
author
show
increment
increas
mfi
indic
ineffect
serum
neutral
lower
concentr
dilut
serum
demonstr
use
evalu
presenc
iav
nab
studi
viral
dissemin
vivo
use
replicationcompet
reporterexpress
iav
remain
challeng
requir
report
signal
detect
tissu
skin
pan
et
al
publish
gener
replicationcompet
iav
harbor
gluc
na
segment
use
backbon
iavgluc
tabl
viral
na
segment
similar
describ
egfp
iavgluc
replic
lower
level
mdck
cell
log
egg
log
compar
wt
viru
author
also
abl
visual
viral
dissemin
live
mice
model
viru
caus
patholog
howev
iavgluc
viru
attenu
vivo
took
iavgluc
achiev
wtlike
patholog
character
bodi
weight
chang
percent
surviv
lung
histopatholog
livemous
imag
antivir
therapeut
studi
use
ivi
found
optim
use
high
dose
pfu
dissemin
importantli
gluc
signal
specif
site
viral
infect
inject
luciferas
substrat
final
author
test
whether
iavgluc
use
evalu
antivir
therapeut
vitro
proofofprincipl
use
antivir
serum
collect
convalesc
mice
previous
infect
iavgluc
preincub
serial
dilut
antivir
serum
serumviru
mixtur
use
infect
mdck
cell
plate
bioluminesc
intens
determin
h
postinfect
result
show
iavgluc
could
complet
inhibit
antivir
sera
demonstr
potenti
use
iavgluc
develop
viral
neutral
assay
evalu
antivir
drug
vitro
vieira
machado
et
al
attempt
gener
replicationcompet
iav
backbon
wsn
harbor
dicistron
na
segment
contain
na
foreign
sequenc
differ
size
either
foreign
gfp
aa
chloramphenicol
acetyl
transferas
cat
aa
fragment
mengoviru
capsid
aa
control
duplic
promot
sequenc
gene
tabl
end
ncr
multipl
clone
site
insert
stop
codon
promot
sequenc
na
segment
figur
despit
numer
attempt
viru
express
gfp
rescu
howev
recombin
virus
express
cat
success
gener
suggest
report
gene
gfp
could
includ
exist
constraint
size
natur
insert
foreign
sequenc
author
demonstr
duplic
promot
use
drive
foreign
gene
express
northern
blot
analysi
vrna
crna
mrna
show
two
naderiv
rna
speci
detect
correspond
fulllength
shorter
subgenom
molecul
compris
report
gene
sequenc
flank
noncod
sequenc
despit
slightli
reduc
na
express
recombin
virus
replic
effici
prove
stabl
upon
serial
passag
mdck
cell
pulmonari
tissu
infect
mice
later
vieira
machado
et
al
gener
novel
recombin
iav
harbor
dicistron
na
segment
extend
termin
sequenc
nt
compris
last
nt
na
orf
ncr
figur
tabl
virus
contain
foreign
gene
virus
replic
stabli
effici
virus
dicistron
na
segment
compris
nativ
ncr
moreov
wherea
dicistron
vrna
could
rescu
infecti
virus
three
virus
rescu
addit
virus
express
foreign
gene
higher
level
virus
cell
cultur
pulmonari
tissu
infect
mice
author
propos
later
recombin
iav
harbor
dicistron
na
segment
develop
live
bival
vaccin
avian
influenza
viru
subtyp
top
world
health
organ
list
greatest
pandem
potenti
inactiv
vaccin
induc
limit
immun
respons
case
liveattenu
influenza
vaccin
laiv
safeti
concern
regard
possibl
reassort
viral
segment
circul
iav
strain
overcom
drawback
pena
et
al
introduc
novel
method
gener
bival
vaccin
influenza
aguinea
fowlhong
influenza
use
viral
genom
rearrang
tabl
achiev
first
remov
nep
ns
viral
segment
nep
replac
ha
orf
separ
fmdv
autocleavag
site
allow
collinear
express
protein
figur
transgen
insert
clone
downstream
either
fulllength
truncat
express
first
ntermin
aa
gene
prevent
normal
splice
activ
ns
segment
donor
site
branch
point
within
fulllength
mutat
stop
codon
insert
earli
residu
open
read
frame
nep
nep
fuse
segment
separ
fmdv
figur
addit
correspond
packag
signal
previous
determin
rna
segment
ns
maintain
end
segment
proof
concept
author
first
use
gfp
gluc
truncat
orf
instead
ha
viral
protein
abl
rescu
infecti
report
express
virus
gluc
respect
recombin
rearrang
iav
reach
titer
order
six
seven
log
egg
infecti
dose
eid
ml
transgen
express
maintain
ten
passag
reduct
viru
titer
rearrang
recombin
ha
backbon
observ
compar
parent
recombin
viru
contain
delet
observ
addit
rearrang
virus
also
attenu
vivo
abl
provid
complet
protect
mice
singl
immun
howev
ha
viru
provid
complet
protect
lethal
challeng
influenza
mice
ferret
also
potenti
pandem
iav
reassort
viru
altogeth
studi
demonstr
rearrang
iav
genom
great
potenti
develop
improv
vaccin
multipl
iav
well
pathogen
express
report
gene
tabl
research
also
rescu
amantadineresist
viru
antivir
drug
screen
purpos
denot
grew
significantli
reduc
titer
level
compar
recombin
wt
counterpart
mdck
cell
multicycl
growth
grew
similar
titer
although
sensit
viru
appear
grow
slightli
higher
titer
resist
viru
genet
stabil
three
separ
replic
evalu
serial
passag
five
time
mdck
cell
three
replic
two
tenfold
decreas
gluc
express
one
tenfold
increas
report
express
passag
although
caus
differ
explor
proofofconcept
sutton
et
al
use
virus
vitro
antivir
screen
microneutr
assay
amantadin
treatment
significantli
decreas
gluc
express
compar
half
maxim
inhibitori
concentr
ic
result
compar
previous
publish
literatur
microneutr
assay
outcom
also
show
similar
result
wt
final
author
show
could
use
vivo
screen
tool
compound
antivir
activ
taken
togeth
provid
anoth
luciferasebas
tool
use
screen
techniqu
identifi
novel
antivir
drug
shorten
time
requir
viru
detect
vitro
vivo
studi
research
use
replicationcompet
iav
contain
modifi
ns
segment
figur
tabl
truncat
maintain
abil
antagon
type
interferon
ifn
allow
insert
foreign
gene
like
gfp
gfpharbor
iav
abl
replic
protein
kinas
r
pkr
knockout
mice
reach
similar
viral
lung
titer
without
gfp
gene
pfug
attenu
wt
mice
vitro
capabl
replic
wtlike
titer
ifndefici
vero
cell
contrast
vero
viru
passag
ifncompet
mdck
cell
result
select
delet
mutant
sequenc
data
mutant
confirm
loss
gfp
express
correl
partial
delet
gfp
orf
delet
heterogen
rang
sever
nucleotid
remov
approxim
c
termin
end
gfp
protein
interestingli
delet
mutant
outcompet
contain
gfp
defici
mutat
certainli
practic
replicationcompet
fluorescentexpress
iav
kittel
et
al
provid
earli
efficaci
genet
strategi
insert
foreign
gene
viral
genom
yield
viabl
progeni
kittel
et
al
also
incorpor
genet
characterist
influenza
b
viru
ibv
use
uniqu
strategi
encod
matrix
protein
initi
codon
overlap
termin
codon
upstream
gene
protein
form
stopstart
pentanucleotid
uaaug
util
ibv
strategi
kittel
et
al
develop
bicistron
recombin
iav
stop
codon
stopstart
cassett
termin
translat
aa
start
codon
reiniti
translat
gfp
figur
tabl
although
express
level
gfp
significantli
lower
obtain
previous
bicistron
iav
appear
replic
compet
mice
show
higher
genet
stabil
fact
viral
isol
deriv
infect
mous
lung
still
capabl
express
gfp
infect
cell
util
bicistron
viru
author
also
express
instead
gfp
although
iav
show
high
titer
mous
lung
display
mortal
rate
infect
anim
addit
viru
show
enhanc
respons
viral
antigen
mice
singl
intranas
immun
result
suggest
influenza
virus
could
engin
express
biolog
activ
molecul
cytokin
immun
modul
purpos
manicassami
et
al
describ
replicationcompet
iav
contain
gfp
fuse
protein
previous
shown
function
activ
iav
nep
could
express
singl
polyprotein
fmdv
autoproteolyt
cleavag
site
manicassami
et
al
modifi
ns
segment
express
nep
singl
polyprotein
porcin
autoproteolyt
cleavag
site
allow
nep
releas
upstream
protein
translat
figur
tabl
order
avoid
splice
ns
mrna
two
silent
mutat
splice
acceptor
site
introduc
replic
like
wt
singlecycl
replic
assay
mdck
cell
show
lower
replic
level
multicycl
assay
wellcharacter
function
iav
protein
counteract
host
type
ifn
respons
shown
also
abl
suppress
ifn
activ
vivo
attenu
evalu
mld
bodi
weight
loss
compar
wt
viru
use
viru
author
studi
viral
dissemin
lung
gfp
observ
lung
infect
mice
ex
vivo
use
ivi
wholeorgan
imag
could
also
observ
use
flow
cytometri
analyz
infect
progress
antigen
present
cell
imag
murin
lung
show
infect
start
respiratori
tract
area
close
larg
conduct
airway
later
spread
deeper
section
lung
author
found
use
pfu
intranas
inocul
dendrit
cell
dc
observ
express
gfp
macrophag
neutrophil
also
gfp
h
postinfect
h
percent
gfpexpress
dc
declin
percentag
fluoresc
macrophag
neutrophil
increas
dose
anim
oseltamivir
limit
gfp
express
antigenpres
cell
amantadin
effect
specif
cell
type
author
howev
acknowledg
antigen
present
cell
could
gfp
due
phagocyt
infect
cell
fact
helft
et
al
use
iav
establish
kinet
infect
transport
drain
lymph
node
tabl
author
provid
evid
lung
dc
transport
viral
antigen
drain
lymph
node
protect
influenza
viru
infect
vivo
induct
viralspecif
cell
immun
mainli
depend
crosspresent
viral
infect
cell
lung
migratori
noninfect
dc
also
report
lung
migratori
dc
express
natur
antivir
state
strengthen
type
ifn
releas
first
hour
follow
influenza
viru
infect
also
use
studi
instanc
hufford
richardson
et
al
util
demonstr
lungresid
neutrophil
infect
iav
tabl
author
suggest
act
stimul
innat
immun
respons
also
activ
lymphocyt
begin
viral
clearanc
lung
innat
immun
system
critic
antivir
clearanc
signal
promot
iav
replic
studi
pang
et
al
shown
innat
immun
activ
trigger
tolllik
receptor
retino
acid
induc
rigi
requir
effici
iav
replic
reparatori
tract
tabl
util
infect
bone
marrowderiv
dc
bmdc
defici
gene
requir
rigi
signal
consist
previou
studi
wt
bmdc
less
suscept
infect
rigi
defici
cell
determin
gfp
fluoresc
comparison
iavinfect
cell
show
inflammatori
mediat
elicit
rigi
signal
recruit
viral
target
cell
airway
therebi
increas
viral
load
within
respiratori
tract
author
suggest
iav
use
physiolog
level
inflammatori
respons
replic
advantag
highlight
complex
interplay
virus
host
innateimmun
respons
studi
resainfant
et
al
show
without
unabl
effici
replic
alveolar
epithelium
tabl
direct
observ
iav
infect
provid
mean
evalu
antivir
therapi
studi
kim
et
al
infect
cell
treat
na
inhibitor
oseltamivir
variou
natur
compound
tabl
oseltamivir
also
use
vivo
treat
infect
mice
case
reduc
gfp
express
indic
limit
neutral
infect
mice
commonli
use
model
iav
infect
vivo
gabor
et
al
report
iav
infect
zebrafish
new
inexpens
model
reproduc
viral
infect
tabl
use
iav
show
zebrafish
support
infect
mount
immun
respons
interestingli
infect
gfp
cell
local
within
cardiovascular
system
swim
bladder
author
point
swim
bladder
liken
iav
infect
human
lung
endotheli
tissu
support
relev
model
due
technic
limit
histor
difficult
monitor
process
iav
infect
modern
fluoresc
microscopi
given
research
abil
use
video
captur
infect
fluorescentexpress
replicationcompet
iav
use
robert
et
al
demonstr
iavinfect
cell
infect
neighbour
cell
pass
viru
actin
protrus
tabl
previou
observ
use
nadefici
virus
treat
infect
cell
na
inhibitor
robert
et
al
show
microplaqu
iav
appear
cell
cultur
howev
addit
actin
inhibitor
microtubul
stabil
oseltamivir
treatment
prohibit
microplaqu
format
live
video
microscopi
show
compel
evid
celltocel
iav
infect
cell
show
gfp
movement
one
cell
anoth
intercellular
connect
coupl
immunofluoresc
data
show
actin
filament
contain
vrnp
connect
infect
uninfect
cell
led
hypothesi
cellfre
virion
infect
method
iav
dissemin
use
similar
construct
eckert
et
al
gener
iav
encod
maxgfp
turborfp
gluc
replic
compar
wt
tabl
research
move
forward
show
greatest
report
stabil
three
virus
turborfp
drop
fluoresc
posit
cell
third
passag
tissu
cultur
sinc
gluc
secret
well
suit
report
high
throughput
antivir
compound
screen
establish
correl
viral
titer
luciferas
activ
zanamivir
iav
na
inhibitor
use
benchmark
infect
human
epitheli
colorect
adenocarcinoma
cell
numer
antivir
factor
express
upon
type
ifn
induct
member
ifninduc
transmembran
ifitm
protein
famili
specif
identifi
inhibitor
iav
author
show
viru
use
investig
cellular
protein
exhibit
inhibitori
function
iav
infect
remark
protein
transduc
mdck
cell
inhibit
prolifer
iav
contrast
inhibitori
effect
observ
upon
express
minor
human
embryon
kidney
cell
absent
mdck
cell
agreement
publish
data
therefor
data
indic
viru
could
use
evalu
antivir
activ
host
cell
protein
fact
previou
studi
suggest
ifitm
protein
act
increas
endosom
cholesterol
author
found
compound
increas
endosom
cholesterol
display
dose
depend
inhibitori
effect
iav
infect
vitro
likewis
nogal
et
al
use
similar
approach
gener
iav
express
monomer
cherri
fluoresc
protein
backbon
respect
tabl
replic
lower
level
wt
mdck
cell
howev
viru
abl
abrog
type
ifn
induct
similarli
wt
importantli
mcherryexpress
virus
inhibit
antivir
typespecif
nab
level
compar
wt
virus
repres
excel
option
rapid
identif
antivir
nab
use
ht
methodolog
author
also
present
potenti
use
vivo
studi
even
though
attenu
mice
inocul
pfu
result
infectionspecif
fluoresc
replic
could
directli
visual
quantifi
whole
excis
lung
use
ivi
result
offer
promis
option
directli
studi
biolog
iav
evalu
experiment
outcom
treat
iav
infect
vitro
ex
vivo
reporterexpress
iav
discuss
thu
far
encod
static
report
optim
determin
origin
chronolog
infect
dynam
fluoresc
protein
timer
engin
chang
emiss
spectra
green
red
time
could
allow
track
iav
detail
timer
deriv
red
fluoresc
protein
discosoma
dsred
contain
two
point
mutat
confer
strong
quantum
yield
spectral
shift
phenotyp
breen
et
al
describ
gener
replicationcompet
virus
express
timer
fuse
viral
protein
backbon
iavtim
influenza
ibvtim
virus
tabl
recombin
iavtim
vitro
show
similar
growth
kinet
compar
wt
viru
use
multipl
approach
includ
fluoresc
microscopi
plaqu
assay
author
abl
differenti
primari
secondarili
infect
cell
timer
express
spectral
shift
quantifi
infect
cell
use
fluoresc
plate
reader
flow
cytometri
importantli
iavtim
use
evalu
dynam
viral
infect
mous
lung
use
ivi
studi
constitut
proofofprincipl
use
recombin
iav
express
dynam
timer
protein
studi
viral
infect
dynam
vitro
vivo
drawback
mani
fluoresc
luminesc
iav
commonli
attenu
vivo
fukuyama
et
al
gener
seri
colorflu
virus
backbon
express
fluoresc
protein
differ
color
venu
ecfp
mcherri
egfp
tabl
fukuyama
et
al
mouseadapt
reporterexpress
iav
serial
passag
mice
viru
variant
ecfp
venu
mcherri
show
higher
pathogen
compar
parent
virus
although
still
less
pathogen
wt
determin
mld
abil
use
four
uniqu
virus
multiplex
test
infect
mice
report
could
observ
cluster
wholelung
explant
use
stereomicroscopi
addit
coinfect
could
observ
lung
tissu
slice
virus
contain
two
fluoresc
report
suggest
colorflu
use
studi
reassort
implic
gener
pandem
strain
iav
along
gener
human
adapt
strain
research
also
appli
analyz
macrophag
respons
iav
infect
macrophag
observ
infiltr
bronchial
epithelium
around
posit
cell
transcriptom
analysi
infect
venusposit
macrophag
show
elev
messag
level
gene
involv
innat
immun
respons
addit
hpai
viru
engin
contain
venu
mahpaivenu
mice
infect
mahpaivenu
result
greater
venusposit
bronchial
epithelium
observ
twophoton
microscopi
also
increas
number
venusposit
macrophag
mahpaivenu
infect
support
find
hpai
virus
induc
sever
inflammatori
respons
lung
infect
mice
therefor
studi
demonstr
util
colorflu
compar
studi
iav
pathogenesi
recombin
iav
discuss
use
singl
autocleavag
site
collinearli
express
fusion
protein
nep
separ
without
need
altern
splice
recent
de
baet
et
al
report
gener
iav
express
gfp
tricistron
ns
segment
backbon
figur
tabl
reduc
size
engin
gene
segment
use
truncat
protein
aa
combin
heterolog
dimer
domain
drosophila
melanogast
nonclaret
disjunct
ncd
protein
increas
protein
stabil
gfp
nep
sequenc
frame
truncat
separ
selfprocess
site
fmdv
respect
hatag
also
fuse
facilit
protein
detect
result
gfp
viru
replic
effici
wt
vitro
retain
report
express
plaqu
passag
mdckv
cell
ifn
respons
block
stabl
express
parainfluenza
viru
type
v
protein
howev
passag
parent
mdck
cell
plaqu
gfpposit
five
passag
recombin
viru
slightli
attenu
vivo
maintain
gfpposit
plaqu
recov
five
day
postinfect
mous
lung
cellular
tropism
gfp
also
evalu
treatment
either
oseltamivir
mab
target
iav
matrix
protein
ectodomain
latter
treatment
interest
base
data
show
efficaci
iav
vaccin
treatment
protect
mice
weight
loss
post
gfp
infect
final
author
demonstr
use
viru
studi
viral
cell
tropism
ex
vivo
prophylact
treatment
mice
mab
oseltamivir
result
decreas
percentag
gfpexpress
cell
futur
studi
must
address
resist
mab
antigen
mutat
protein
could
nullifi
treatment
reuther
et
al
also
report
gener
iav
express
gfp
tricistron
ns
segment
backbon
figur
tabl
result
virus
encod
luciferas
fluoresc
protein
maintain
high
genet
stabil
vitro
round
passag
human
cell
character
vivo
therefor
recombin
virus
gener
could
readili
employ
antivir
compound
screen
addit
visual
infect
cell
cell
surviv
acut
infect
purpos
review
discuss
biolog
applic
replicationcompet
iav
express
commonli
use
fluoresc
luciferas
report
gene
plasmidbas
revers
genet
techniqu
allow
simultan
express
iav
rnadepend
rna
polymeras
rdrp
negativestrand
genom
viral
segment
transient
transfect
mammalian
cell
togeth
gener
de
novo
rescu
recombin
iav
moreov
techniqu
allow
use
recombin
dna
technolog
modifi
genom
iav
engin
virus
express
foreign
gene
recombin
reporterexpress
replicatingcompet
iav
applic
translat
research
demonstr
screen
platform
identifi
specif
broadli
reactiv
nab
antivir
compound
host
protein
involv
viral
replic
fact
gener
recombin
reporterexpress
iav
lead
design
cellbas
assay
captur
stage
viru
lifecycl
replicatingcompet
report
virus
greater
flexibl
choic
cell
perform
assay
provid
increas
potenti
identifi
inhibitor
viral
cellular
function
critic
optim
viru
replic
moreov
fluorescentor
luciferaseexpress
iav
shown
valuabl
asset
vivo
studi
use
conjunct
new
imag
technolog
combin
fluoresc
luminesc
gene
plu
gener
report
iav
use
differ
backbon
includ
hpai
pandem
strain
increas
spectrum
tool
use
facilit
studi
iav
futur
area
replicationcompet
iav
applic
includ
limit
viru
tropism
analysi
viral
reassort
replic
vaccin
develop
conclus
potenti
advantag
disadvantag
associ
replicationcompet
iav
howev
number
applic
well
abund
econom
quantit
biolog
advantag
iav
highlight
promis
applic
basic
translat
influenza
research
immin
futur
acknowledg
want
thank
influenza
virologist
whose
work
contribut
gener
recombin
replicatingcompet
reporterexpress
iav
would
want
apolog
inadvert
omit
manuscript
describ
gener
recombin
replicatingcompet
iav
express
report
gene
influenza
viru
research
lui
laboratori
partial
fund
niaid
center
excel
influenza
research
surveil
ceir
author
contribut
author
wrote
manuscript
author
declar
conflict
interest
